PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer

Roncolato, F; Lindemann, K; Wilson, ML; Martyn, J; Mileshkin, L

Roncolato, F (reprint author), NHMRC Clin Trials Ctr, Med Oncol, Chris OBrien Lifehouse,Level 6,119 143 Missenden, Camperdown, NSW 2050, Australia.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019; (10):

Abstract

Background Endometrial cancer is one of the most common gynaecological cancers in developed countries. Treatment of advanced endometrial cancer usuall......

Full Text Link